OMICS Journal of Radiology
Open Access

In the dynamic landscape of medical technology, the quest for more effective and nuanced approaches to breast cancer diagnosis has led to the emergence of microwave imaging as a promising and revolutionary tool. As one of the latest additions to the armamentarium of medical imaging, microwave technology offers a fresh perspective on detecting and characterizing breast abnormalities [1]. This article delves into the transformative impact of emerging technologies, specifically microwave imaging, on breast cancer diagnosis, exploring the innovative strides made in recent years and their potential to reshape the landscape of women’s healthcare.

Breast cancer remains a formidable global health challenge, necessitating continual advancements in diagnostic methodologies to enhance early detection and improve patient outcomes. Traditional imaging modalities, such as mammography and ultrasound, have been instrumental in breast cancer diagnosis, yet their limitations in terms of sensitivity, specificity, and safety have spurred the exploration of alternative technologies [2]. Microwave imaging, with its unique ability to harness non-ionizing electromagnetic waves and exploit the inherent differences in tissue properties, presents a novel avenue for addressing these challenges.

In this context, it becomes imperative to examine the recent technological advancements that have propelled microwave imaging into the spotlight, paving the way for a more precise, patient-centric, and efficient approach to breast cancer diagnosis. From three-dimensional reconstructions enabled by microwave tomography to real-time monitoring facilitated by radar-based imaging, these innovations hold the potential to redefine our understanding of breast cancer detection.

Moreover, the integration of machine learning algorithms with microwave imaging data marks a critical juncture where computational intelligence enhances diagnostic accuracy [3]. This synergistic coupling offers not only the promise of improved sensitivity in identifying subtle abnormalities but also the potential to reduce false positives, thereby minimizing the psychological and physical burden on patients.

As we embark on a journey through the intricacies of microwave imaging and its evolving role in breast cancer diagnosis, this exploration aims to shed light on the promises, challenges, and future implications of this groundbreaking technology. The ultimate goal is to discern how microwave imaging stands poised to revolutionize breast cancer diagnostics, offering new hope in the fight against one of the most prevalent and impactful diseases affecting women worldwide [4].

Microwave Imaging: An Overview

Microwave imaging utilizes electromagnetic waves with frequencies ranging from hundreds of megahertz to several gigahertz to create detailed images of the internal structures of the breast. Unlike traditional imaging modalities such as mammography, which uses X-rays, or ultrasound, which uses sound waves, microwave imaging offers a unique advantage by exploiting the different dielectric properties of normal and cancerous breast tissues [5].

Key Advantages

Non-ionizing radiation

Unlike X-rays used in mammography, microwave imaging employs non-ionizing radiation, making it a safer option for frequent screenings,especially in younger women. Microwave imaging is a promising new method for early-stage breast cancer detection. This is based on the contrast of electric parameters between the tumor and the normal breast tissue within the microwave spectrum. The method reconstructs the breast image from the received signals that are scattered and reflected within the breast. While the resolution becomes higher as the frequency increases, tissue loss increases [6]. Thus, it is difficult to obtain a clear image, so a limit of upper frequency of the band is needed for acceptable penetration into the tissue. An ultra-wideband signal is appropriate for these conditions. Since the penetration loss of healthy fat tissue is less than 4 dB/cm with microwave signal which is centered at 6 GHz, it is possible to reach low power signal to an antenna on the other side of an object.

Increased sensitivity to tissue properties

Microwave imaging is highly sensitive to variations in tissue properties, allowing for better differentiation between healthy and cancerous tissues.

Improved contrast resolution

The technique provides superior contrast resolution compared to traditional methods, enabling more accurate identification of earlystage tumors [7].

Recent Technological Advancements

Microwave tomography

Advances in microwave tomography have allowed for threedimensional reconstructions of breast tissue, providing a more comprehensive view and enhancing the accuracy of tumor localization.

The goal of microwave tomography is to recover the profile using the inverse problem of the dielectric properties of the breast. Microwave tomography uses an inverse scattering method to get a breast diagnostic image. Inverse scattering uses scattering signals including diffraction from objects. It creates a map of permittivity and conductivity through inversion of those signals [8]. However, the inverse problem takes much time, because the calculation process is complicated. Also, a nonlinear inverse scattering problem must be solved, and iterative image reconstruction algorithms are usually required to obtain a solution. In general, these ill-posed inverse scattering approaches suffer from nonuniqueness and require regularization in order to achieve convergence to a meaningful solution.

Radar-based imaging

Microwave radar technology has been incorporated into breast imaging, allowing for real-time monitoring and dynamic assessment of tissue properties.

A 3D image of the received signals through the breast is obtained by focusing algorithms. Before applying the focusing algorithm, preprocessing is performed to obtain a tumor response [9]. Preprocessing may contain the extracting tumor response, compensation tissue losses, or radial spread. Among the preprocessing, extracting tumor response must be conducted, because the received signal includes not only the tumor response, but also unwanted signals such as antenna coupling, directly received signals from the transmit antenna, and reflections from the skin.

Machine learning integration

The integration of machine learning algorithms with microwave imaging data has significantly improved diagnostic accuracy. These algorithms can analyze complex patterns and aid in the early identification of suspicious lesions.

Clinical Implications

Early detection and intervention

Microwave imaging has shown promise in detecting smaller tumors and lesions at earlier stages, potentially leading to more effective and less invasive treatment options.

Personalized treatment plans

The detailed information provided by microwave imaging can contribute to the development of personalized treatment plans tailored to the specific characteristics of each patient’s tumor.

Reduced false positives

The improved specificity of microwave imaging helps reduce falsepositive results, minimizing unnecessary biopsies and the associated patient anxiety [10].

Challenges and Future Directions

Standardization and validation

Standardizing protocols and validating the effectiveness of microwave imaging across diverse patient populations are essential steps for widespread clinical adoption.

Integration with other modalities

Combining microwave imaging with existing modalities, such as mammography and magnetic resonance imaging (MRI), could enhance overall diagnostic accuracy.

Conclusion

Microwave imaging stands at the forefront of revolutionary changes in breast cancer diagnosis. With its non-ionizing nature, enhanced sensitivity, and recent technological advancements, it holds great promise for improving early detection rates and subsequently transforming the outcomes for individuals diagnosed with breast cancer. As researchers and clinicians continue to collaborate, the integration of microwave imaging into routine breast cancer screening protocols could become a reality, marking a significant milestone in the field of women’s health.

1. Khor B, Gardet A, Xavier RJ (2011) Genetics and pathogenesis of inflammatory bowel disease. Nature 474: 307-317.

Indexed at, Google Scholar, Crossref

2. Danese S, Fiocchi C (2011) Ulcerative colitis. N Engl J Med 365: 1713-1725.

Indexed at, Crossref

3. Loftus EV Jr. (2004) Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126: 1504-1517.

Indexed at, Google Scholar, Crossref

4. Kaplan GG, Ng SC (2017) Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology 152: 313-321.

Indexed at, Google Scholar, Crossref

5. Matsuoka K, Kanai T (2015) The gut microbiota and inflammatory bowel disease. Semin Immunopathol 37: 47-55.

Indexed at, Google Scholar, Crossref

6. El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576.

Indexed at, Google Scholar, Crossref

7. Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379: 1245-1255.

Indexed at, Crossref

8. Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, et al (2018) Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 68: 723-750.

Indexed at, Google Scholar, Crossref

9. Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, et al. (2020) Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N Engl J Med 382: 1894-1905.

Indexed at, Google Scholar, Crossref

10. Bruix J, Takayama T, Mazzaferro V, Chau GY, Yang J, et al. (2015) Adjuvant Sorafenib for Hepatocellular Carcinoma after Resection or Ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Oncol 16: 1344-1354.

Indexed at, Google Scholar, Crossref